What is Gilead Sciences's investing cash flow?

Gilead Sciences (GILD) reported investing cash flow of $1.77B in Q1 2026.

How has Gilead Sciences's investing cash flow changed year-over-year?

Gilead Sciences's investing cash flow increased by 526.5% year-over-year, from -$415M to $1.77B.

What is the long-term trend for Gilead Sciences's investing cash flow?

Over 4 years (2021 to 2025), Gilead Sciences's investing cash flow has grown at a 11.2% compound annual growth rate (CAGR), from -$3.13B to -$4.79B.

What does investing cash flow mean?

Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Gilead Sciences GILD Investing Cash Flow

Investing Cash Flow at other companies

Bristol-Myers SquibbBMY

-$131M+73.7%

IncyteINCY

-$88.2M-8,140%

ImmunityBio, Inc.IBRX

-$31.65M-867%

PrecigenPGEN

$20.97M+425%

AnaptysBio, Inc.ANAB

$34.98M+136%

Iovance Biotherapeutics, Inc.IOVA

$11.39M-28.2%

Other financials

Income statement

See full

Revenue$7.0B+4.4%

Gross profit$5.5B+7.6%

Operating income$2.6B+15.6%

Net income$2.0B+53.7%

EPS (diluted)$1.61+54.8%

Balance sheet

See full

Cash & equivalents$7.6B-3.8%

Total debt$22.2B-11.1%

Total equity$23.5B+22.7%

Total assets$56.3B-0.3%

Cash flow

See full

Operating cash flow$2.5B+44.8%

CapEx$117.0M+12.5%

Free cash flow$2.4B+46.8%

Valuation

See full

Market cap$156.86B+21.7%

Enterprise value$171.41B+15.5%

P/E17×-3.4×

P/S5.3×+0.8×

Profitability

See full

Gross margin79.4%+1.1pp

Operating margin34.9%+6.3pp

Net margin31%+10.2pp

FCF margin34.4%+0.1pp

Returns & leverage

See full

Return on equity43.2%+10.7pp

Debt / equity0.9×-0.4×

Current ratio2×+0.6×

Where this comes from

Reported directly by Gilead Sciences in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The official record: Gilead Sciences’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gilead Sciences's investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Gilead Sciences's investing cash flow?: Gilead Sciences (GILD) reported investing cash flow of $1.77B in Q1 2026.
How has Gilead Sciences's investing cash flow changed year-over-year?: Gilead Sciences's investing cash flow increased by 526.5% year-over-year, from -$415M to $1.77B.
What is the long-term trend for Gilead Sciences's investing cash flow?: Over 4 years (2021 to 2025), Gilead Sciences's investing cash flow has grown at a 11.2% compound annual growth rate (CAGR), from -$3.13B to -$4.79B.
What does investing cash flow mean?: Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.